Evidence map›Paper›PMID 8321198›Full record

ArticleMolecular and cellular biology1993

Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.

E Shi, M Kan, J Xu, F Wang, J Hou, W L McKeehan

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 124 citations in OpenAlex.

  1. FGF signaling in cranial suture development and related diseases.Frontiers in cell and developmental biology · 2023
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Fibroblast growth factors, old kids on the new block.Seminars in cell & developmental biology · 2016
    Review
  7. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.International journal of clinical and experimental pathology · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. FGFR3-related dwarfism and cell signaling.Journal of bone and mineral metabolism · 2009
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E ShiW. Alton Jones Cell Science Center, Inc., Lake Placid, New York 12946.
M Kan
J Xu
F Wang
J Hou
W L McKeehan
W. Alton Jones Cell Science Center · US

Funding

HUMAN HEPATOCYTE GROWTH FACTORSR01DK035310 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MCKEEHAN, WALLACE LEE · 1986 to 2006
$1.9M
HUMAN HEPARIN-BINDING GROWTH FACTOR RECEPTORSR01DK040739 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MCKEEHAN, WALLACE LEE · 1989 to 2002
$768k
TRACHEAL CELLSP01CA037589 · NCI · ADIRONDACK BIOMEDICAL RESEARCH INSTITUTE · PI MANSSON, PER-ERIK · 1985 to 1992
–
NCI NIH HHS CA37589NIDDK NIH HHS DK35310NIDDK NIH HHS DK40739
6 · The paper itself

Abstract

A differentiated liver cell (HepG2), which exhibits a dose-dependent growth-stimulatory and growth-inhibitory response to heparin-binding fibroblast growth factor type 1 (FGF-1), displays high- and low-affinity receptor phenotypes and expresses specific combinatorial splice variants alpha 1, beta 1, and alpha 2 of the FGF receptor (FGF-R) gene (flg). The extracellular domains of the alpha and beta variants consist of three and two immunoglobulin loops, respectively, while the intracellular variants consist of a tyrosine kinase (type 1) isoform and a kinase-defective (type 2) isoform. The type 2 isoform is also devoid of the two major intracellular tyrosine autophosphorylation sites (Tyr-653 and Tyr-766) in the type 1 kinase. An analysis of ligand affinity, dimerization, autophosphorylation, and interaction with src homology region 2 (SH2) substrates of the recombinant alpha 1, beta 1, and alpha 2 isoforms was carried out to determine whether dimerization of the combinatorial splice variants might explain the dose-dependent opposite mitogenic effects of FGF. Scatchard analysis indicated that the alpha and beta isoforms exhibit low and high affinity for ligand, respectively. The three combinatorial splice variants dimerized in all combinations. FGF enhanced dimerization and kinase activity, as assessed by receptor autophosphorylation. Phosphopeptide analysis revealed that phosphorylation of Tyr-653 was reduced relative to phosphorylation of Tyr-766 in the type 1 kinase component of heterodimers of the type 1 and type 2 isoforms. The SH2 domain substrate, phospholipase C gamma 1 (PLC gamma 1), associated with the phosphorylated type 1-type 2 heterodimers but was phosphorylated only in preparations containing the type 1 kinase homodimer. The results suggest that phosphorylation of Tyr-653 within the kinase catalytic domain, but not Tyr-766 in the COOH-terminal domain, may be stringently dependent on a trans intermolecular mechanism within FGF-R kinase homodimers. Although phosphotyrosine 766 is sufficient for interaction of PLC gamma 1 and other SH2 substrates with the FGF-R kinase, phosphorylation and presumably activation of substrates require the kinase homodimer and phosphorylation of Tyr-653. We propose that complexes of phosphotyrosine 766 kinase monomers and SH2 domain signal transducers may constitute unactivated presignal complexes whose active or inactive fate depends on homodimerization with a kinase or heterodimerization with a kinase-defective monomer, respectively. The results suggest a mechanism for control of signal transduction by different concentrations of ligand through heterodimerization of combinatorial splice variants from the same receptor gene.

Indexed as

ExonsRNA SplicingSignal TransductionAmino Acid SequenceAnimalsCattleCell LineCloning, MolecularElectrophoresis, Polyacrylamide GelFibroblast Growth FactorsFilaggrin ProteinsHaplorhiniHumansImmunoglobulinsMolecular Sequence DataPhosphopeptidesFibroblast Growth FactorsFilaggrin ProteinsFLG protein, humanImmunoglobulinsPhosphopeptidesProtein KinasesReceptors, Fibroblast Growth Factor

Identifiers

PMID8321198
PMCPMC359927
OpenAlexW2109847676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.